gastrointestinal glucose absorption, and reduce liver glucose production by simulating the action of insulin-like peptide-1. Simeglutide has also been studied for weight management. At higher doses, semaglutide has been developed as a drug for the treatment of obesity. This drug has shown excellent performance in clinical trials, with significant therapeutic effects and high safety